BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,190
-380 (-2.16%)
Jun 5, 2025, 3:30 PM KST
28.28%
Market Cap 531.59B
Revenue (ttm) 140.13B
Net Income (ttm) -25.29B
Shares Out 30.92M
EPS (ttm) -817.69
PE Ratio n/a
Forward PE 55.39
Dividend n/a
Ex-Dividend Date n/a
Volume 483,699
Average Volume 1,045,553
Open 17,570
Previous Close 17,570
Day's Range 17,080 - 18,010
52-Week Range 12,800 - 27,300
Beta 1.33
RSI 52.57
Earnings Date May 15, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 616
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.